Depleting P2X7-specific hcAb may thus be used directly to eliminate tumor cells and additionally to deplete Treg (i.e., T cells expressing higher levels of P2X7) potentially resulting in the induction of two synergistic anti-tumor mechanisms. This evidence concerns the gene P2RX7 and neoplasm.